Pharma BD Deal Intelligence
Furthers Endo's evolution from a product-driven company to a healthcare solutions provider... Strengthens Endo's leading core urology franchise while…
MassDevice noted the device-industry implications: AMS gave Endo a leadership position in pelvic health surgical implants, but raised the question of whether…
This acquisition is a great step in achieving Endo's core strategy. We are creating a company uniquely positioned to respond to the changing healthcare…
Source summaries from our enrichment pipeline; follow links for originals.
All 7 sources with sentiment breakdown →
Endo Pharmaceuticals agreed to acquire American Medical Systems for $30.00 per share, approximately $2.9 billion including assumed debt, announced April 2011 and completed June 2011. The transaction diversified Endo beyond specialty pharma into urology and pelvic-health medical devices (incontinence, ED, BPH and prolapse implants) as a hedge against its branded-drug patent cliffs. Endo later divested the Men's Health business to Boston Scientific in 2015 and wound down Women's Health amid pelvic-mesh litigation.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Endo Pharmaceuticals Inc. / American Medical Systems Holdings, Inc. (this deal) | 2011 | $2.9B | 13 |
| Endo Pharmaceuticals Inc. / Algos Pharmaceutical Corporation | 2000 | $250M | 34 |
| Endo Pharmaceuticals Inc. / Indevus Pharmaceuticals, Inc. | 2009 | $370M | 33 |
| Endo Pharmaceuticals Inc. / SkyePharma plc | 2003 | $120M | 17 |
| Endo Pharmaceuticals Inc. / HealthTronics, Inc. | 2010 | $223M | 17 |
| Endo Pharmaceuticals Inc. / Qualitest Pharmaceuticals | 2010 | $1.2B | 17 |
| Endo Pharmaceuticals Inc. / Penwest Pharmaceuticals Co. | 2010 | $144M | 13 |
← Browse all deals · How we score deals
More: 2011 deals · Endo Pharmaceuticals Inc. deals · Other deals